BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2703744)

  • 1. Vitiligo following type II lepra reaction.
    Pavithran K
    Indian J Lepr; 1989 Jan; 61(1):44-8. PubMed ID: 2703744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lepromatous leprosy with drug reaction.
    Baxt RD
    Dermatol Online J; 2000 Sep; 6(1):9. PubMed ID: 11328619
    [No Abstract]   [Full Text] [Related]  

  • 3. High prevalence of vitiligo in lepromatous leprosy.
    Boisseau-Garsaud AM; Vezon G; Helenon R; Garsaud P; Saint-Cyr I; Quist D
    Int J Dermatol; 2000 Nov; 39(11):837-9. PubMed ID: 11123444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cold abscesses in a borderline lepromatous patient on multidrug therapy.
    Kulkarni V; Gharpuray MB; Kulkarni DS
    Indian J Lepr; 1989 Oct; 61(4):442-4. PubMed ID: 2621380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and bacteriological relapse after MDT in a lepromatous patient: a case report.
    Shanker PV
    Indian J Lepr; 1991; 63(2):229-31. PubMed ID: 1783792
    [No Abstract]   [Full Text] [Related]  

  • 8. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of histoid leprosy responding to ofloxacin along with standard MDT.
    Vora NS; Vora VN; Mukhopadhyay AK; Roy K; Patel NN; Ghosh A
    Indian J Lepr; 1995; 67(2):183-6. PubMed ID: 8537707
    [No Abstract]   [Full Text] [Related]  

  • 10. Lucio leprosy with lucio phenomenon.
    Saoji V; Salodkar A
    Indian J Lepr; 2001; 73(3):267-72. PubMed ID: 11840599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New multidrug regimen with indigenous drugs and dapsone in the treatment of lepromatous leprosy (preliminary report).
    Chaudhury S; Hazra S; Podder GC; Poddar S; Sarkar S; Das PK; Chaudhury SN; Majumder V
    Indian J Dermatol; 1987 Jul; 32(3):63-7. PubMed ID: 3504207
    [No Abstract]   [Full Text] [Related]  

  • 13. Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
    Robati RM; Mozafari N; Bidari-Zerehpoosh F; Niknejad N; Bizaval Z
    Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy.
    Walker SL; Lockwood DN
    Clin Dermatol; 2007; 25(2):165-72. PubMed ID: 17350495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
    Jamet P; Blanc L; Fayne OC; Traore I; Bobin P
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):209-14. PubMed ID: 8046259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N; Gavalas NG; Weetman AP; Kemp EH
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patient with Hansen disease and lepromatous reaction with predominant neural involvement].
    Gálvez J; López-Domínguez JM; Navarro A; Creagh R; Casado JL; Chinchón Lara I
    Neurologia; 1998 Jan; 13(1):41-4. PubMed ID: 9522583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histoid leprosy; report of three cases.
    Krishna KK
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):174-6. PubMed ID: 10472376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.